Abstract Bacteriophage–antibiotic coadministration is increasingly used for refractory infections, yet the in vivo interactions among phages, bacteria, antibiotics, and host immunity remain poorly defined. We report a longitudinal, multiomic case analysis of a male in his seventies with cystic fibrosis (CF) experiencing an acute-on-chronic pulmonary exacerbation caused by multidrug-resistant (MDR) Pseudomonas aeruginosa.
Dwayne R. Roach
As seen in:
Nature,
Wiley Online Library,
Frontiers,
MDPI,
Cell Press,
ASM Journals,
Clinical Therapeutics
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Dwayne R. Roach
Pseudomonas aeruginosa ventricular assist device infections: findings from ineffective phage therapies in five cases
Editor's Pick Antimicrobial Chemotherapy Research Article Get full access to this article View all available purchase options and get full access to this article. REFERENCES 1. Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. 2023. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res 118:3272–3287. 2.
Human Neutrophil Response to Pseudomonas Bacteriophage PAK_P1, a Therapeutic Candidate
1. Introduction As a key component of the innate immune system, neutrophils are generally considered rapid responders in the first line of defense against pathogen invasion. They are the predominant population among leukocytes and can clear pathogens by a number of mechanisms, including phagocytosis, production of reactive oxygen species (ROSs) and other antimicrobial products, as well as neutrophil extracellular traps (NETs) [1,2].
Biotic countermeasures that rescue Nannochloropsis gaditana from a Bacillus safensis infection
Introduction Microalgal bacterial communities (hereafter referred to as bacteriomes) coexist within the algal phycosphere in most ecosystems (Sapp et al., 2007; Seymour et al., 2017). Attempts to cultivate a bacteria-free or axenic microalgal monoculture have been shown to be unsuccessful and negatively impact growth (Droop and Elson, 1966; Jones et al., 1973) or the stability of cultures (Godwin et al., 2018).
Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
Abstract Purpose Widespread antibiotic-resistant bacteria are threatening the arsenal of existing antibiotics. Not only are antibiotics less likely to be effective today, but their extensive use continues to drive the emergence of multidrug-resistant pathogens. A new-old antibacterial strategy with bacteriophages (phages) is under development, namely, phage therapy.
Standardized bacteriophage purification for personalized phage therapy
Abstract The world is on the cusp of a post-antibiotic era, but researchers and medical doctors have found a way forward—by looking back at how infections were treated before the advent of antibiotics, namely using phage therapy. Although bacteriophages (phages) continue to lack drug approval in Western medicine, an increasing number of patients are being treated on an expanded-access emergency investigational new drug basis.
Circulating neutrophil and eosinophil extracellular traps are markers of severe asthma
LETTER TO THE EDITOR Circulating neutrophil and eosinophil extracellular traps are markers of severe asthma Vanessa Granger APHP, Hôpital Bichat, UF Auto‐immunité et Hypersensibilités, HUPNVS, Paris, France Inflammation Chimiokines et Immunopathologie, INSERM UMR996, Faculté de Pharmacie, Université Paris‐Sud, Université Paris‐Saclay, Châtenay‐Malabry, France Search for more papers by this author Camille Taillé APHP, Hôpital Bichat, Service de Pneumologie A, HUPNVS, Paris, France INSERM, UMR...
Correction: Magnetic Cell Labeling of Primary and Stem Cell-Derived Pig Hepatocytes for MRI-Based Cell Tracking of Hepatocyte Transplantation
Dr. Dorela D. Shuboni-Mulligan is not included in the author byline. She should be listed as the fourth author and affiliated with 1: Molecular and Cellular Imaging Laboratory, Department of Radiology, Michigan State University, East Lansing, Michigan, United States of America. The contributions of this author are as follows: Conceived and designed the experiments, performed the experiments, wrote the paper.
Synergy between the Host Immune System and Bacteriophage Is Essential for Successful Phage Therapy against an Acute Respiratory Pathogen
The rise of multi-drug-resistant (MDR) bacteria has spurred renewed interest in the use of bacteriophages in therapy. However, mechanisms contributing to phage-mediated bacterial clearance in an animal host remain unclear. We investigated the effects of host immunity on the efficacy of phage therapy for acute pneumonia caused by MDR Pseudomonas aeruginosa in a mouse model.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Dwayne R.
Contact Dwayne R., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack